Miller Fisher Syndrome Following Vaccination against SARS-CoV-2.

Yamakawa, Makoto; Nakahara, Keiichi; Nakanishi, Toshihito; Nomura, Toshiya; Ueda, Mitsuharu

Yamakawa, Makoto; Nakahara, Keiichi; Nakanishi, Toshihito; Nomura, Toshiya; Ueda, Mitsuharu.

Afiliação

Yamakawa M; Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Japan.
Nakahara K; Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Japan.
Nakanishi T; Department of Neurology, Kumamoto Kinoh Hospital, Japan.
Nomura T; Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Japan.
Ueda M; Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Japan.

Intern Med ; 61(7): 1067-1069, 2022.

Article em En | MEDLINE | ID: mdl-35370249

Assuntos

COVID-19; Síndrome de Miller Fisher; Adulto; Vacina BNT162; COVID-19/prevenção & controle; Gangliosídeos; Humanos; Masculino; Síndrome de Miller Fisher/diagnóstico; Síndrome de Miller Fisher/tratamento farmacológico; Síndrome de Miller Fisher/etiologia; SARS-CoV-2; Vacinação

Palavras-chave

COVID-19; Miller Fisher syndrome; SARS-CoV-2; adverse event; vaccine

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Síndrome de Miller Fisher / COVID-19 Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Adult / Humans / Male Idioma: En Revista: Intern Med Assunto da revista: MEDICINA INTERNA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google